logo
Sign in

TBET Stock Price, Chart, Stats & News

Tibet Pharmaceuticals, Inc.
Save

Tibet Pharmaceuticals, Inc. (TBET) does not currently pay a dividend.

1,485
Market cap
0.01x
Current P/E
Forward P/E

TBET chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Tibet Pharmaceuticals, Inc. operates as a specialized pharmaceutical company, primarily focused on the research, development, manufacturing, marketing, and distribution of traditional Tibetan medicines. The company conducts its core activities through its operational subsidiary, Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (YSTP), which develops products within China to support the health of human respiratory, digestive, urinary, and reproductive systems. Among its currently commercialized products are: 25 Ingredients Mandrake Pill: Used for menstrual regulation and to address conditions like endometritis, pelvic inflammations, and anemia in women. 15 Ingredients Gentiana Pill: Prescribed for respiratory ailments including bronchitis, emphysema, asthma, and hoarseness. 28 Ingredients Pinang Pill: Aims to alleviate cold waist and hip pain, pus hematuria, and testicular swelling. 18 Ingredients Chebulic (Myrobalan) Frusemide Pill: Designed to treat various kidney issues, lower back and kidney pain, frequent or turbid urination, diabetes, and spermatorrhea.

Similar securities

Based on sector and market capitalization

Report issue